21 May 2013
Keywords: strong, ph, iii, data, wyeth, desvenlafaxine, usa
Article | 05 June 2006
The USA's Wyeth Pharmaceuticals presented Phase III data and results from other studies concerning its investigational drug for major
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
5 June 2006
29 May 2006
20 May 2013
© 2013 thepharmaletter.com